Berlin, Germany – December 22, 2025
BEBIG Medical GmbH, a global provider of radiation therapy solutions with over 50 years of clinical experience, today announced CE Certificate for its linear accelerator SagiStar on December 22, 2025, a major milestone in its mission to provide affordable healthcare for everyone. Designed to advance precise treatment with affordable solutions, SagiStar represents a leap forward for BEBIG Medical in radiotherapy industry.

A Strategic Expansion of BEBIG Medical’s Radiation Therapy Portfolio

For decades, BEBIG Medical has been widely recognized for its expertise in brachytherapy, intraoperative radiation therapy (IORT), and X-ray therapy systems, with more than 700 active installations in over 80 countries and regions worldwide.
The successful CE certification of the linear accelerator represents a natural and strategic extension of the company’s long-term commitment to delivering complete, reliable, and clinically proven radiation therapy solutions.

“Achieving CE certification for our linear accelerator is a major milestone for BEBIG Medical,” said George, CEO of BEBIG Medical GmbH.

“It reflects years of dedicated research and development, close collaboration with our partners, and our unwavering focus on quality and patient safety. This milestone allows us to offer a more comprehensive radiotherapy solution to clinics worldwide.”

Designed for Clinical Reliability and Global Accessibility

Developed with a strong focus on clinical performance, operational stability, and cost efficiency, BEBIG Medical’s linear accelerator is designed to meet the needs of both established and emerging radiotherapy markets.

The system aims to support healthcare providers in delivering accurate, efficient, and accessible cancer treatments, aligning with BEBIG Medical’s mission to make advanced radiation therapy technologies available worldwide.

Moving Toward Clinical Implementation and Global Deployment

With the CE certificate now granted, BEBIG Medical will proceed with:

• Market introduction and clinical deployment in CE-mark-recognized regions

• Close collaboration with clinical partners for initial installations

• Ongoing training, service, and long-term support through its global distributor network

“This certification is beginning of the next phase,” BEBIG Medical’s CEO George said.

“This certification is part of BEBIG Medical’s long-term strategy to provide a complete and sustainable radiotherapy portfolio. It enables us to better support our clinical partners while maintaining our focus on safety, reliability, and responsible growth.”

About BEBIG Medical

BEBIG Medical GmbH is a global provider of radiation therapy products dedicated to cancer treatment, with over 50 years of experience and a proven track record of clinical outcomes achieved through robust and innovative technology.

The company specializes in the research and development, manufacturing, and worldwide distribution of radiation therapy devices, offering a comprehensive product portfolio including linear accelerators, high-dose-rate brachytherapy systems, X-ray therapy products, and intraoperative radiation therapy solutions.

With offices and professionals located across Europe, the United States, and Asia, and supported by a network of more than 70 global distributors, BEBIG Medical is committed to making high-quality, affordable cancer treatment solutions accessible worldwide.